Latest Therapeutic Goods Administration News

How wellness clinics bend the rules to supply unapproved peptides and anti-ageing injections
TGA Product Information Safety Updates 20 July
Unapproved peptide product promoters and suppliers are put on notice
New Regulations Strengthen Controls On Nicotine Pouches
AMA welcomes announcement on nicotine pouches but calls for more action
New information relating to s 9D(1) applications for listed medicines
TGA leads crackdown of illegal nicotine products across Darwin
Monash University joins TGA Academic Outreach Program
TGA Acts On Melatonin Imports
There’s one reason why so many cold and flu tablets don’t actually work
Canngea Pty Ltd issued infringement notices totalling $59,400 for alleged failure to comply with a request for information about the supply of…
Take control of your learning journey and understand your regulatory obligations
Withania Somnifera And Very Rare Risk Of Liver Injury
Darolutamide (Nubeqa) – Hope for men with high-risk non-metastatic hormone resistant prostate cancer
TGA issues infringement notices to nurse for alleged unlawful importation of cosmetic injectables
Under-qualified prescribing of controlled medicines poses risk to public health
New UDI requirements for medical devices commence 1 July 2026
Listed Medicine Compliance Reports – June 2026 Update
Delays In Care Present Greatest Risk To Patients
MDMA and psilocybin therapy rules have been relaxed. Here’s what might happen next
Under-qualified prescribing of controlled medicines poses risk to public health
Optimi Health Completes Psilocybin Export to Australia for Patients With Treatment-Resistant Depression
Operation TEMPEST sweeps VIC and TAS in major illicit tobacco and vaping crackdown
Re-frame imperfect hearing with TGA approved Nuance Audio(TM) Glasses
Concerns regarding the public health risks associated with unapproved peptide products
Update To Listed Medicine Ingredients In June 2026
TGA releases new guidance on advertising restrictions for prescription medicines
TGA issues infringement notices to a health professional and an individual for alleged unlawful importation of cosmetic injectables
Does paraquat cause Parkinson’s? Here’s what the evidence says about this common weed killer
TGA Product Information Safety Updates 15 June
Consumer Medicines Line To Close On 30 July 2026
What to know if you’ve been prescribed medicinal cannabis
Do your patients know the risks of unapproved medicinal cannabis products?
AMA President’s update: Reconciliation Week, hidden costs of vertical integration, inter-professional collaboration, advocacy, AGM, and more
First-in-human trial of cholesterol-lowering genetic therapy to begin at Victorian Heart Hospital
Stronger sunscreen rules needed to restore confidence and protect Australians
Landmark approval of Tzield in Australia ushers in a new era of delay for type 1 diabetes
Updates to Authorised Prescriber (AP) scheme requirements when accessing MDMA and psilocybine
Health practitioners – how to access medicines during a national shortage
First-in-human trial of cholesterol-lowering genetic therapy to begin at Victorian Heart Hospital
Individual issued 27 infringement notices for allegedly supplying Melanotan II
Lapse of provisional registration for Andexxa (andexanet alfa) used for Factor Xa inhibitor (apixaban/rivaroxaban) reversal
New ‘AI scientists’ are improving – but reveal their fundamental limits
Updates To Prescribing Medicines In Pregnancy Database 19 May
Unlawful Therapeutic Goods Seized In Global Operation
Forging an integrative health research alliance with India
Tranexamic acid: risk of serious adverse events after inadvertent spinal administration
New TGA guidance clarifies requirements for compounded medicines